Published in Am J Pathol on January 01, 1998
Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A (1998) 7.69
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest (1999) 3.21
Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci U S A (1998) 3.18
Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate. J Virol (2002) 2.43
Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog Neurobiol (2007) 2.18
In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J Virol (1998) 2.09
HIV-1 associated dementia: symptoms and causes. Retrovirology (2006) 1.70
CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol (2004) 1.52
Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. J Virol (1999) 1.40
Variation in HIV-1 R5 macrophage-tropism correlates with sensitivity to reagents that block envelope: CD4 interactions but not with sensitivity to other entry inhibitors. Retrovirology (2008) 1.37
Interferon-independent, human immunodeficiency virus type 1 gp120-mediated induction of CXCL10/IP-10 gene expression by astrocytes in vivo and in vitro. J Virol (2001) 1.35
Aging sensitizes mice to behavioral deficits induced by central HIV-1 gp120. Neurobiol Aging (2006) 1.33
Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am J Pathol (2000) 1.33
Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol Neurobiol (2007) 1.15
Microglial activation varies in different models of Creutzfeldt-Jakob disease. J Virol (1999) 1.13
HIV and HIV dementia. J Clin Invest (2000) 1.10
Lymphotropic virions affect chemokine receptor-mediated neural signaling and apoptosis: implications for human immunodeficiency virus type 1-associated dementia. J Virol (1999) 1.10
Cocaine differentially modulates chemokine production by mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients. Clin Diagn Lab Immunol (2000) 1.00
Differential long-term neurotoxicity of HIV-1 proteins in the rat hippocampal formation: a design-based stereological study. Hippocampus (2008) 0.97
How much do antiretroviral drugs penetrate into the central nervous system? J Med Life (2011) 0.91
Regulation of human immunodeficiency virus type 1 infection, beta-chemokine production, and CCR5 expression in CD40L-stimulated macrophages: immune control of viral entry. J Virol (2001) 0.88
Neuronal toxicity in HIV CNS disease. Future Virol (2012) 0.85
Apelin, the natural ligand of the orphan seven-transmembrane receptor APJ, inhibits human immunodeficiency virus type 1 entry. J Virol (2000) 0.84
Dose-dependent long-term effects of Tat in the rat hippocampal formation: a design-based stereological study. Hippocampus (2010) 0.84
Bioinformatic analysis of HIV-1 entry and pathogenesis. Curr HIV Res (2014) 0.83
HIV subtype is not associated with dementia among individuals with moderate and advanced immunosuppression in Kampala, Uganda. Metab Brain Dis (2014) 0.82
Physiological evidence for interaction between the HIV-1 co-receptor CXCR4 and the cannabinoid system in the brain. Br J Pharmacol (2009) 0.82
Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation. Int J Dev Neurosci (2014) 0.81
Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors. Int Rev Neurobiol (2014) 0.81
Excitotoxic brain injury stimulates expression of the chemokine receptor CCR5 in neonatal rats. Am J Pathol (1998) 0.80
Contribution of CNS cells in NeuroAIDS. J Pharm Bioallied Sci (2010) 0.79
Gene expression profiles and protein-protein interaction network analysis in AIDS patients with HIV-associated encephalitis and dementia. HIV AIDS (Auckl) (2015) 0.78
Human immunodeficiency virus glycoprotein 160 induces cytokine mRNA expression in the rat central nervous system. Cell Mol Neurobiol (2000) 0.75
HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science (1996) 26.19
Identification of a major co-receptor for primary isolates of HIV-1. Nature (1996) 23.81
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature (1996) 20.59
CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science (1996) 18.53
Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell (1996) 17.81
The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell (1996) 17.13
Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature (1996) 15.91
A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell (1996) 14.64
Change in coreceptor use correlates with disease progression in HIV-1--infected individuals. J Exp Med (1997) 11.01
The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med (1996) 10.62
Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 8.45
The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci U S A (1997) 8.27
CD4-independent infection by HIV-2 is mediated by fusin/CXCR4. Cell (1996) 6.52
The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science (1988) 6.51
CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature (1997) 5.45
CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med (1997) 5.18
Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol (1995) 3.78
Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group. N Engl J Med (1997) 3.71
Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med (1995) 2.73
Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. N Engl J Med (1989) 2.72
Clinical-neuropathologic correlation in HIV-associated dementia. Neurology (1993) 2.47
Immunohistochemical identification of HTLV-III antigen in brains of patients with AIDS. Ann Neurol (1986) 2.37
CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr Biol (1997) 2.35
Pathologic features of AIDS encephalopathy in children: evidence for LAV/HTLV-III infection of brain. Hum Pathol (1986) 2.23
Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann Neurol (1996) 2.22
A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J Immunol (1997) 2.15
Neocortical damage during HIV infection. Ann Neurol (1991) 2.15
Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol (1997) 2.10
Neurologic manifestations of human immunodeficiency virus infection in children. Pediatrics (1986) 2.09
Human immunodeficiency virus type 1 infection alters chemokine beta peptide expression in human monocytes: implications for recruitment of leukocytes into brain and lymph nodes. Proc Natl Acad Sci U S A (1996) 2.02
CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am J Pathol (1997) 2.00
HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology (1994) 1.86
Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol (1996) 1.83
Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology (1994) 1.80
Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosylceramide-independent mechanism. Proc Natl Acad Sci U S A (1993) 1.73
Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol (1993) 1.73
Evidence of apoptotic cell death in HIV encephalitis. Am J Pathol (1995) 1.63
Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol (1992) 1.61
Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS (1995) 1.59
Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res (1994) 1.50
Neural apoptosis. Ann Neurol (1995) 1.49
Neurological complications in infants and children with acquired immune deficiency syndrome. Ann Neurol (1985) 1.47
Loss of neurons in the frontal cortex in AIDS brains. Acta Neuropathol (1990) 1.45
Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol Appl Neurobiol (1995) 1.41
Neuronal apoptosis in HIV infection in adults. Neuropathol Appl Neurobiol (1995) 1.40
Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Invest (1996) 1.40
Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol (1991) 1.34
Role of mesenchymal cell death in lung remodeling after injury. J Clin Invest (1993) 1.34
Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J Neuropathol Exp Neurol (1990) 1.29
Neurological and neuropathological features of human immunodeficiency virus infection in children. Ann Neurol (1988) 1.26
Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non-AIDS cases. J Neuropathol Exp Neurol (1992) 1.23
Effect of nef alleles on replication of human immunodeficiency virus type 1. Virology (1993) 1.20
Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis (1994) 1.10
Neurovirulent simian immunodeficiency virus infection induces neuronal, endothelial, and glial apoptosis. Mol Med (1996) 1.09
Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am J Pathol (1992) 1.08
Markers and determinants of disease progression in children with HIV infection. The Pediatric AIDS Siena Workshop II. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 0.94
Human immunodeficiency virus within the brains of children with AIDS. Clin Neuropathol (1990) 0.93
Programmed cell death in brains of HIV-1-positive AIDS and pre-AIDS patients. Acta Neuropathol (1996) 0.88
AIDS in Romania. Am J Med Sci (1992) 0.80
Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature (1975) 10.33
Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) (2008) 9.45
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA (1999) 9.18
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. N Engl J Med (2013) 8.89
Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet (2005) 7.25
Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J Virol (1990) 6.54
Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res (2000) 6.42
Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. N Engl J Med (1969) 6.15
Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci U S A (1991) 5.78
Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med (1999) 5.61
CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature (1997) 5.45
Internists' and surgeons' attitudes toward guns and firearm injury prevention. Ann Intern Med (1998) 5.15
Support for new policies to regulate firearms. Results of two national surveys. N Engl J Med (1998) 5.06
Plasma digoxin concentrations in patients with atrial fibrillation. Br Med J (1970) 4.82
Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody. J Virol (1991) 4.82
Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab (2001) 4.53
J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry (1991) 4.11
Expression of luminal and basal cytokeratins in human breast carcinoma. J Pathol (2004) 3.80
The reliability of Cancer Registry records. Br J Cancer (1993) 3.70
Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol (1985) (2000) 3.54
Seeing the herpesvirus capsid at 8.5 A. Science (2000) 3.35
Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA (1997) 3.27
A meta-analytic review of research on hostility and physical health. Psychol Bull (1996) 3.27
Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med (1971) 3.27
Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivity. J Virol (1991) 3.09
Intra-aneurysmal thrombosis as a possible cause of delayed aneurysm rupture after flow-diversion treatment. AJNR Am J Neuroradiol (2010) 3.03
Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia (2003) 3.00
Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion. J Virol (1990) 2.95
Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem (1996) 2.82
Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol (2001) 2.79
Disruption of Ini1 leads to peri-implantation lethality and tumorigenesis in mice. Mol Cell Biol (2001) 2.76
The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nat Med (1999) 2.76
Experimental investigation of geologically produced antineutrinos with KamLAND. Nature (2005) 2.75
Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration. J Clin Invest (1970) 2.66
Polygenic susceptibility in rheumatoid arthritis. Ann Rheum Dis (1991) 2.66
The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues. Br J Pharmacol (1977) 2.59
Complete genome sequence of the shrimp white spot bacilliform virus. J Virol (2001) 2.58
Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med (1993) 2.55
The effect of feeding with a tryptophan-free amino acid mixture on rat-liver polysomes and ribosomal ribonucleic acid. Biochem J (1966) 2.53
Assembly of VP26 in herpes simplex virus-1 inferred from structures of wild-type and recombinant capsids. Nat Struct Biol (1995) 2.51
A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50
Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med (1976) 2.49
Spinal cord stimulation facilitates functional walking in a chronic, incomplete spinal cord injured. Spinal Cord (2002) 2.47
Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology (2003) 2.43
Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension (2001) 2.42
Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes. J Pharmacol Exp Ther (2004) 2.42
The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. J Neurooncol (2013) 2.41
The human transmissible spongiform encephalopathies (TSEs): implications for dental practitioners. Br Dent J (2000) 2.41
Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin. Biochemistry (1970) 2.39
Suspected low-grade glioma: is deferring treatment safe? Ann Neurol (1992) 2.37
Role of Vif in human immunodeficiency virus type 1 reverse transcription. J Virol (1996) 2.35
Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study. Am J Psychiatry (2001) 2.34
Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A (1993) 2.32
Methadone dosage and retention of patients in maintenance treatment. Med J Aust (1991) 2.31
Stress and body shape: stress-induced cortisol secretion is consistently greater among women with central fat. Psychosom Med (2001) 2.30
Angiotensin-converting-enzyme gene insertion/deletion polymorphism and response to physical training. Lancet (1999) 2.27
Leukemia following Hodgkin's disease. N Engl J Med (1990) 2.25
The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J Virol (1994) 2.22
A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol (1995) 2.20
Linkage of COL1A2 collagen gene to cystic fibrosis, and its clinical implications. Lancet (1985) 2.14
Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol (2001) 2.09
Legume consumption and risk of coronary heart disease in US men and women: NHANES I Epidemiologic Follow-up Study. Arch Intern Med (2001) 2.08
Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest (1996) 2.07
Cloning and characterization of a second member of the mouse mdr gene family. Mol Cell Biol (1988) 2.06
Electron correlation effects in resonant inelastic X-ray scattering of NaV2O5. Phys Rev Lett (2002) 2.06
Doctors detected self-administering opioids in New South Wales, 1985-1994: characteristics and outcomes. Med J Aust (1998) 2.04
Intensive treatment of multiple myeloma and criteria for complete remission. Lancet (1989) 2.04
Medullomyoblastoma. A histologic, immunohistochemical, and ultrastructural study. Cancer (1984) 2.03
Contributions of community involvement to organizational-level empowerment: the federal Healthy Start experience. Health Educ Behav (2001) 2.03
Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol (2001) 2.03
Nitric oxide and cardiac function. Circ Res (1996) 2.01
Role of vif during packing of the core of HIV-1. Virology (1994) 2.01
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology (1994) 1.97
Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension (2000) 1.96
Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study. N Engl J Med (1986) 1.96
Disease in children infected with HIV in Abidjan, Côte d'Ivoire. BMJ (1996) 1.92
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: different prion proteins determined by a DNA polymorphism. Proc Natl Acad Sci U S A (1994) 1.85
Effect of intravenous streptokinase on early mortality in patients with suspected acute myocardial infarction. A meta-analysis by anatomic location of infarction . Ann Intern Med (1990) 1.82
Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem (1995) 1.80
An acute ischemic stroke classification instrument that includes CT or MR angiography: the Boston Acute Stroke Imaging Scale. AJNR Am J Neuroradiol (2008) 1.80
HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis (1996) 1.79
Causes of death among people with convulsive epilepsy in rural West China: a prospective study. Neurology (2011) 1.77
Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy. J Neurosurg (1990) 1.76
Leukemia following chemotherapy for ovarian cancer. N Engl J Med (1990) 1.76
Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med (1993) 1.75
Completeness of cancer registration: a new method for routine use. Br J Cancer (2000) 1.75
Allelic variation in the effects of the nef gene on replication of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1991) 1.75
In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74
Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J Cell Biol (1997) 1.74
Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest (2000) 1.72
Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. N Engl J Med (1998) 1.71
Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens (2004) 1.71
Detection of secondary predation by PCR analyses of the gut contents of invertebrate generalist predators. Mol Ecol (2005) 1.71
Effects of larval mosquitoes (Aedes triseriatus) and stemflow on microbial community dynamics in container habitats. Appl Environ Microbiol (1999) 1.70
Suggestive linkage of the parathyroid receptor type 1 to osteoporosis. J Bone Miner Res (1999) 1.69
Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant (2009) 1.69
Serum immunoreactive trypsin in cystic fibrosis. Thorax (1981) 1.68